Class 2 Medicines Recall: Various Marketing Authorisation Holders and parallel distributor companies, irbesartan-containing products

The MHRA has issued a Medicines Recall for specific batches of products supplied by the Marketing Authorisation Holders and parallel distributor companies due to presence of a mutagenic impurity. [Please note that a batch expiry date has been updated on 13th August - see note below for further details]

Join OnMedica and benefit from:

  • Bitesize CPD and easy to digest content, free for UK-based GPs and specialist doctors
  • High-quality, evidence-based content developed by expert editors and clinicians
  • Articles, quizzes, videos, visual summaries and more
  • Regulatory alerts and round-up of medical journals
  • New content added daily, so you know you’re always up to date

Existing members Sign in

Sorry, we need to confirm your details before you can access this content.

If you have just signed up to OnMedica, you are seeing this message because we couldn’t automatically verify that you are a practising doctor in the UK. Please check your email inbox as we may need a few more details to validate your OnMedica membership. If you haven’t received an email from us or you need assistance, please contact